Trial to Assess the Efficacy and Safety of LEO 152020 in Adult Patients With Cholinergic Urticaria

Status:
Recruiting

Trial end date:
2021-12-20

Target enrollment:

Participant gender:

Phase 2a trial to assess the efficacy and safety of LEO 152020 in adult patients with cholinergic urticaria

Phase 2

LEO Pharma